nuvaxovid
novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.
nuvaxovid 0.5 ml injektionsdispersion
future health pharma gmbh - sars cov-2 rs nvx-cov2373 - injektionsdispersion - sars cov-2 rs nvx-cov2373 5 µg, adjuvans matrix-m: saponinum fraction-a 42.5 µg et saponinum fraction-c 7.5 µg ex quillaja saponariae molina extractum purificatum, cholesterolum, phosphatidylcholinum, int-rac-alpha-tocopherolum, kalii dihydrogenophosphas, kalii chloridum, dinatrii phosphas dihydricus, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, natrii chloridum, polysorbatum 80, natrii hydroxidum q.s. ad ph, acidum hydrochloridum q.s. ad ph, aqua ad iniectabile q.s. ad praeparationem pro 0.5 ml corresp., natrium 4.0 mg, kalium 0.003 mg. - aktive immunisierung zur vorbeugung der durch das sars-cov-2-virus verursachten coronavirus-2019-erkrankung (covid-19) ab 12 jahren - vaccini
novalac ar1 latte in polvere 800g
a.menarini ind.farm.riun.srl -
novalac as2 latte polvere 800g
a.menarini ind.farm.riun.srl -
novalac s 1 latte in polvere 800g
a.menarini ind.farm.riun.srl -
novalac ar2 latte in polvere 800g
a.menarini ind.farm.riun.srl -